ATE124257T1 - Granulate mit hohem ibuprofengehalt. - Google Patents

Granulate mit hohem ibuprofengehalt.

Info

Publication number
ATE124257T1
ATE124257T1 AT90902888T AT90902888T ATE124257T1 AT E124257 T1 ATE124257 T1 AT E124257T1 AT 90902888 T AT90902888 T AT 90902888T AT 90902888 T AT90902888 T AT 90902888T AT E124257 T1 ATE124257 T1 AT E124257T1
Authority
AT
Austria
Prior art keywords
binder
percent
polyvinylpyrrolidone
granules
ibuprofen
Prior art date
Application number
AT90902888T
Other languages
English (en)
Inventor
Larry E Denton
Anil M Salpekar
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ATE124257T1 publication Critical patent/ATE124257T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT90902888T 1989-02-02 1990-01-31 Granulate mit hohem ibuprofengehalt. ATE124257T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/306,014 US4911921A (en) 1989-02-02 1989-02-02 High ibuprofen content granulations

Publications (1)

Publication Number Publication Date
ATE124257T1 true ATE124257T1 (de) 1995-07-15

Family

ID=23183358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90902888T ATE124257T1 (de) 1989-02-02 1990-01-31 Granulate mit hohem ibuprofengehalt.

Country Status (10)

Country Link
US (1) US4911921A (de)
EP (1) EP0456720B1 (de)
JP (1) JP2556623B2 (de)
AT (1) ATE124257T1 (de)
AU (1) AU629913B2 (de)
CA (1) CA2045680C (de)
DE (1) DE69020541T2 (de)
DK (1) DK0456720T3 (de)
ES (1) ES2076358T3 (de)
WO (1) WO1990008542A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104648A (en) * 1989-02-02 1992-04-14 Mallinckrodt Specialty Chemicals Company High ibuprofen content granulations
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
US5310961A (en) * 1993-07-02 1994-05-10 Affinity Biotech, Inc. Neomorphic ibuprofen
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6251945B1 (en) 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
UA75831C2 (en) 2002-04-29 2006-05-15 Egyt Gyogyszervegyeszeti Gyar Process for preparation of tablets from pharmaceutically active ingredients having unfavourable tabletting properties with the use of granulating liquid containing microcrystalline cellulose
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
WO2006007095A2 (en) * 2004-06-30 2006-01-19 Albemarle Corporation High ibuprofen content granules and their preparation and use
EP1741712B1 (de) 2004-07-30 2011-06-15 Torrent Pharmaceuticals Ltd amorphes nebivolol hydrochlorid und seine Herstellung
DK1884242T3 (da) 2005-05-26 2013-05-06 Dainippon Sumitomo Pharma Co Farmaceutisk sammensætning omfattende lurasidon
CA2577760A1 (en) * 2006-02-27 2007-08-27 Tyco Healthcare Group Lp Pressurized dip coating system
US20080069889A1 (en) * 2006-03-07 2008-03-20 Cherukuri S R Compressible resilient granules and formulations prepared therefrom
US20070212417A1 (en) * 2006-03-07 2007-09-13 Cherukuri S R Compressible resilient granules and formulations prepared therefrom

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
US4661521A (en) * 1984-04-30 1987-04-28 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
US4757090A (en) * 1986-07-14 1988-07-12 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen

Also Published As

Publication number Publication date
DE69020541D1 (de) 1995-08-03
DK0456720T3 (da) 1995-08-14
AU629913B2 (en) 1992-10-15
JP2556623B2 (ja) 1996-11-20
AU5036990A (en) 1990-08-24
DE69020541T2 (de) 1995-11-02
EP0456720B1 (de) 1995-06-28
ES2076358T3 (es) 1995-11-01
WO1990008542A1 (en) 1990-08-09
JPH04503069A (ja) 1992-06-04
US4911921A (en) 1990-03-27
CA2045680A1 (en) 1990-08-03
CA2045680C (en) 1997-01-14
EP0456720A1 (de) 1991-11-21

Similar Documents

Publication Publication Date Title
ATE124257T1 (de) Granulate mit hohem ibuprofengehalt.
DK0560092T3 (da) Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer
DE3877764D1 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
ATE125155T1 (de) Niedrigdosierte getrocknete pharmazeutische präparate.
DE3879080D1 (de) Pharmazeutische matrix mit verzoegerter freisetzung und verfahren.
AU7419687A (en) Sustained release pharmaceutical preparations
UA5328A1 (uk) Спосіб одержання таблеток
DE69001488D1 (de) Mittel auf gemfibrozilbasis mit modifizierter freigabe.
GR3006498T3 (de)
JPS5759803A (en) Granule of l-sodium ascorbate, its preparation, and tablet comprising it
GR900300172T1 (en) Processes for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related products
IL82065A0 (en) Pellet-containing delayed release pharmaceutical and veterinary composition and its preparation
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
DE69214333D1 (de) Arzneizubereitung mit hohem Gehalt an Ibuprofenlysinat
ES2072561T3 (es) Perborato de sodio.
Hontz Assessment of Selected formulation and processing variables in fluid bed granulation
TH13475A (th) สูตรผสมทางเภสัชกรรม
RU2000125696A (ru) Бронхолитическое средство и способ его получения
ATE78159T1 (de) Feste arzneiform mit hohem verapamil-gehalt.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time